Kelly E. Dooley, MD, PhD, MPH
Professor of Medicine
Professor, Department of Medicine, Division of Infectious Diseases
Director, Division of Infectious Diseases
Kelly Dooley, MD, PhD, MPH, is Professor of Medicine, and Director of the Division of Infectious Diseases within the Department of Medicine at Vanderbilt University Medical Center (VUMC). As an infectious disease specialist and clinical pharmacologist, Dr. Dooley maintains an active clinical practice in HIV care. Her research focuses on tuberculosis therapeutics with an emphasis on clinical trials of TB drugs and HIV/TB co-treatment, as well as clinical pharmacology of TB and HIV drugs. She is lead investigator for trials of therapeutics for drug-sensitive and drug-resistant TB, TB-HIV, and pediatric TB meningitis. She is on the TB scientific committees of the AIDS Clinical Trials Group and IMPAACT networks and is a consultant to World Health Organization on TB therapeutics and pharmacology.
Dr. Dooley earned her Master of Public Health in Epidemiology from University of North Carolina at Chapel Hill, and her medical degree from Duke University. She completed her Internal Medicine residency, and fellowships in Infectious Diseases and Clinical Pharmacology at Johns Hopkins University. She subsequently earned a PhD in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. She joined VUMC in 2022, and is board certified in internal medicine and infectious diseases.
MPH - Epidemiology - University of North Carolina at Chapel Hill - 1998
MD - Duke University - 1999
Internship - Internal Medicine - The Johns Hopkins Hospital - 2000
Residency - Internal Medicine - The Johns Hopkins Hospital - 2002
Fellowship - Clinical Infectious Diseases - The Johns Hopkins Hospital - 2008
PhD - Clinical Investigation - Johns Hopkins Bloomberg School of Public Health - 2009
Fellowship - Research Clinical Pharmacology - The Johns Hopkins Hospital - 2010